Literature DB >> 9403726

Prostatic neuroendocrine cells have a unique keratin expression pattern and do not express Bcl-2: cell kinetic features of neuroendocrine cells in the human prostate.

Y Xue1, A Verhofstad, W Lange, F Smedts, F Debruyne, J de la Rosette, J Schalken.   

Abstract

We investigated the keratin phenotype and bcl-2 immunoreactivity of neuroendocrine cells in the human prostate to determine whether the postmitotic status of these cells is associated with protection from apoptosis by bcl-2 protein expression and to elucidate the possible cell kinetic relationship between neuroendocrine cells and the other epithelial components of the prostate. Tissue specimens were selected from prostates of 19 patients harboring normal secretory glands (n = 15) and glandular benign prostatic hyperplasia (n = 10). Using a novel sequentially selective destaining immunoenzymatic cytochemical technique we were able to demonstrate the distribution of neuroendocrine cells, keratin markers identifying either basal, luminal, or intermediate cells, and the bcl-2 protein in single sections. Basal cell keratins were expressed in the minority of the neuroendocrine cells. In most of the cells, intermediate and luminal cell keratins were found and bcl-2 was constantly negative. Our findings indicate that neuroendocrine cells and other epithelial cells in the human prostate share a common keratin phenotype and probably originate from a common epithelial precursor. From the absence of bcl-2 we infer that the neuroendocrine cells have no progenitor cell characteristics.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9403726      PMCID: PMC1858366     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  38 in total

1.  Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer.

Authors:  T J McDonnell; P Troncoso; S M Brisbay; C Logothetis; L W Chung; J T Hsieh; S M Tu; M L Campbell
Journal:  Cancer Res       Date:  1992-12-15       Impact factor: 12.701

2.  BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death.

Authors:  D M Hockenbery; M Zutter; W Hickey; M Nahm; S J Korsmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

Review 3.  A review of intermediate filament biology and their use in pathologic diagnosis.

Authors:  R B Nagle
Journal:  Mol Biol Rep       Date:  1994-01       Impact factor: 2.316

Review 4.  Kinetics of adrenal medullary cells.

Authors:  A A Verhofstad
Journal:  J Anat       Date:  1993-10       Impact factor: 2.610

5.  Keratin profiles in normal/hyperplastic prostates and prostate carcinoma.

Authors:  H Okada; A Tsubura; A Okamura; H Senzaki; Y Naka; Y Komatz; S Morii
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

6.  Colocalization of basal and luminal cell-type cytokeratins in human prostate cancer.

Authors:  A P Verhagen; F C Ramaekers; T W Aalders; H E Schaafsma; F M Debruyne; J A Schalken
Journal:  Cancer Res       Date:  1992-11-15       Impact factor: 12.701

7.  Keratin expression in cervical cancer.

Authors:  F Smedts; F Ramaekers; S Troyanovsky; M Pruszczynski; M Link; B Lane; I Leigh; C Schijf; P Vooijs
Journal:  Am J Pathol       Date:  1992-08       Impact factor: 4.307

8.  Extracellular matrix components induce endocrine differentiation in vitro in NCI-H716 cells.

Authors:  A P de Bruïne; W N Dinjens; E P van der Linden; M M Pijls; P T Moerkerk; F T Bosman
Journal:  Am J Pathol       Date:  1993-03       Impact factor: 4.307

Review 9.  Neuroendocrine differentiation in human prostatic carcinoma.

Authors:  P A di Sant'Agnese
Journal:  Hum Pathol       Date:  1992-03       Impact factor: 3.466

Review 10.  Etiology and disease process of benign prostatic hyperplasia.

Authors:  J T Isaacs; D S Coffey
Journal:  Prostate Suppl       Date:  1989
View more
  6 in total

1.  Prostate epithelial stem cell culture.

Authors:  David L Hudson
Journal:  Cytotechnology       Date:  2003-03       Impact factor: 2.058

2.  Kinetics of neuroendocrine differentiation in an androgen-dependent human prostate xenograft model.

Authors:  J Jongsma; M H Oomen; M A Noordzij; W M Van Weerden; G J Martens; T H van der Kwast; F H Schröder; G J van Steenbrugge
Journal:  Am J Pathol       Date:  1999-02       Impact factor: 4.307

3.  Distribution, shape, and immunohistochemical characteristics of serotonin-immunoreactive neuroendocrine cells in the urethra and periurethral genital organs in mice.

Authors:  Kei-Ichiro Uemura; Tasuku Hiroshige; Kosuke Ueda; Keisuke Ohta; Tokumasa Hayashi; Shingo Hirashima; Tomonoshin Kanazawa; Makoto Nakiri; Tsukasa Igawa; Kei-Ichiro Nakamura
Journal:  J Mol Histol       Date:  2021-10-12       Impact factor: 2.611

4.  Neuroendocrine differentiation in prostate cancer.

Authors:  Yin Sun; Junyang Niu; Jiaoti Huang
Journal:  Am J Transl Res       Date:  2009-02-05       Impact factor: 4.060

5.  Resistance to androgen receptor signaling inhibition does not necessitate development of neuroendocrine prostate cancer.

Authors:  W Nathaniel Brennen; Yezi Zhu; Ilsa M Coleman; Susan L Dalrymple; Lizamma Antony; Radhika A Patel; Brian Hanratty; Roshan Chikarmane; Alan K Meeker; S Lilly Zheng; Jody E Hooper; Jun Luo; Angelo M De Marzo; Eva Corey; Jianfeng Xu; Srinivasan Yegnasubramanian; Michael C Haffner; Peter S Nelson; William G Nelson; William B Isaacs; John T Isaacs
Journal:  JCI Insight       Date:  2021-04-22

6.  Cytoskeleton reorganization as an alternative mechanism of store-operated calcium entry control in neuroendocrine-differentiated cells.

Authors:  Karine Vanoverberghe; V'yacheslav Lehen'kyi; Stéphanie Thébault; Maylis Raphaël; Fabien Vanden Abeele; Christian Slomianny; Pascal Mariot; Natalia Prevarskaya
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.